Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stefano Casola is active.

Publication


Featured researches published by Stefano Casola.


Oncogene | 1997

Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.

Stefano Casola; Paolo V. Pedone; Andrea O. Cavazzana; Giuseppe Basso; Roberto Luksch; Emanuele S.G. d'Amore; Modesto Carli; Carmelo B. Bruni; Andrea Riccio

The expression of Insulin-like Growth Factor 2 (IGF-2) and H19, two genes located on human chromosome 11p15 and provided with cell growth modulating activity, is regulated by parental imprinting, in that the activity of their alleles is dependent on the parental origin. Parental bias in the genetic alterations of chromosome 11p15 observed in several pediatric cancers suggests the involvement of imprinted genes in tumor development. We have previously reported that the number of functional IGF-2 alleles is frequently increased in rhabdomyosarcoma (RMS), as a consequence of either relaxation of imprinting (LOI) or gene duplication. Here we show that the expression of the H19 gene is significantly suppressed with respect to normal muscle tissue in 13 out of 15 rhabdomyosarcomas with embryonal histology (ERMS) and in three out of 11 rhabdomyosarcomas classified as alveolar subtype (ARMS). Since a growth-inhibitory activity has been found associated with the H19 gene, the extinction of its expression can contribute to RMS development. Parental imprinting of the H19 gene was found conserved in all informative RMSs, including those whose IGF-2 imprinting was relaxed, indicating that LOI is a gene-specific event. Seven ERMSs and one ARMS displaying low H19 RNA levels showed an underrepresentation of the expressed allele in their genotype. This result is consistent with the paternal imprinting of the H19 gene and with the preferential loss of the maternal 11p15 alleles in these neoplasms. Low H19 expression was also found in four out of eight RMSs retaining the heterozygosity at 11p15, but showing IGF-2 LOI. These findings suggest that the genetic and epigenetic alterations affecting chromosome 11p15 in a high number of RMSs cause deregulation of more than one imprinted gene, possibly affecting tumor growth, including the extinction of H19 expression and an increase in the number of active IGF-2 alleles.


American Journal of Human Genetics | 2000

Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes.

Maria Pia Sperandeo; Paola Ungaro; Maria Vernucci; Paolo V. Pedone; Flavia Cerrato; Lucia Perone; Stefano Casola; Maria Vittoria Cubellis; Carmelo B. Bruni; Generoso Andria; Gianfranco Sebastio; Andrea Riccio

Beckwith-Wiedeman syndrome (BWS) and Klippel-Trenaunay-Weber syndrome (KTWS) are different human disorders characterized, among other features, by tissue overgrowth. Deregulation of one or more imprinted genes located at chromosome 11p15.5, of which insulin-like growth factor 2 (IGF2) is the most likely candidate, is believed to cause BWS, whereas the etiology of KTWS is completely obscure. We report a case of BWS and a case of KTWS in a single family. The probands, sons of two sisters, showed relaxation of the maternal IGF2 imprinting, although they inherited different 11p15.5 alleles from their mothers and did not show any chromosome rearrangement. The patient with BWS also displayed hypomethylation at KvDMR1, a maternally methylated CpG island within an intron of the KvLQT1 gene. The unaffected brother of the BWS proband shared the same maternal and paternal 11p15.5 haplotype with his brother, but the KvDMR1 locus was normally methylated. Methylation of the H19 gene was normal in both the BWS and KTWS probands. Linkage between the insulin-like growth factor 2 receptor (IGF2R) gene and the tissue overgrowth was also excluded. These results raise the possibility that a defective modifier or regulatory gene unlinked to 11p15.5 caused a spectrum of epigenetic alterations in the germ line or early development of both cousins, ranging from the relaxation of IGF2 imprinting in the KTWS proband to disruption of both the imprinted expression of IGF2 and the imprinted methylation of KvDMR1 in the BWS proband. Analysis of these data also indicates that loss of IGF2 imprinting is not necessarily linked to alteration of methylation at the KvDMR1 or H19 loci and supports the notion that IGF2 overexpression is involved in the etiology of the tissue hypertrophy observed in different overgrowth disorders, including KTWS.


Oncogene | 2000

The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.

Maria Vernucci; Flavia Cerrato; Nathalie Besnard; Stefano Casola; Paolo V. Pedone; Carmelo B. Bruni; Andrea Riccio

The expression of the linked but reciprocally imprinted Igf2 and H19 genes is activated in adult liver in the course of tumor development. By in situ hybridization analysis we have shown that both the Igf2 and H19 RNAs are expressed in the majority of the neoplastic nodules, and that hepatocellular carcinomas are developed in an experimental model of liver carcinogenesis. H19 is also highly activated in smaller and less distinct hyperplastic regions. The few neoplastic areas showing Igf2 but no H19 RNA display loss of the maternally inherited allele at the Igf2/H19 locus. These data are compatible with the existence of a common activation mechanism of these two genes during liver carcinogenesis and with a stronger H19 induction in the pre-neoplastic lesions. By using mice carrying a deletion of the H19 endodermal enhancer, we show that this regulatory element is necessary for the activation of the Igf2 and H19 genes upon induction of liver carcinogenesis. Furthermore, multiple sites of the H19 endodermal enhancer region become hypersensitive to DNase I when the carcinogenesis process is induced. Lastly, liver tumors developed in mice paternally inheriting the H19 enhancer deletion are found to have marked growth delays, increased frequency of apoptotic nuclei, and lack of Igf2 mRNA expression, thus indicating that this regulatory element plays a major role in the progression of liver carcinogenesis, since it is required for the activation of the anti-apoptotic Igf2 gene.


Molecular and Cellular Endocrinology | 1997

Relaxation of insulin-like growth factor-2 imprinting in rat cultured cells

Paola Ungaro; Stefano Casola; Maria Vernucci; Paolo V. Pedone; Carmelo B. Bruni; Andrea Riccio

The parental-specific expression of the insulin-like growth factor-2 (Igf-2) and H19 genes was studied in rat fibroblast cells derived from a 3 day-old first-generation hybrid animal obtained by crossing Fisher and Wistar strains (F x W cells). Results showed that the reciprocal imprinting of the Igf-2 and H19 genes was conserved in the rat tissues and in the derived F x W cells when cultured with frequent transfer. Igf-2 and H19 gene expression was coordinately up-regulated upon reaching confluence, but Igf-2 RNA levels were further increased in a time-dependent manner and the repressed state of the maternal Igf-2 allele was progressively relaxed in cultures held in the confluent state and in the presence of low serum for more than 3 days. The active expression and relaxed imprinting status of the Igf-2 gene persisted over cell generations when the growth-constraining conditions were released by trypsinization and dilution. On the contrary, the imprinting of the H19 gene appeared to be unaffected by changes in growth conditions and its expression was down-regulated when the confluent cells were passaged. Methylation of the H19 promoter and Igf-2 coding regions was increased in the F x W cells extensively held under confluence and in the derived post-confluent cultures. The heritable changes in the expression, and imprinting status of the Igf-2 and H19 genes observed in the F x W cells closely resembles events described in human embryonal cancers and cancer-predisposing syndromes. The occurrence of imprinting relaxation under strong growth-inhibitory conditions supports the hypothesis that it is an epigenetic change.


Advances in Experimental Medicine and Biology | 1991

EXTINCTION OF HUMAN INSULIN-LIKE GROWTH FACTOR II EXPRESSION IN SOMATIC CELL HYBRIDS

Raffaele Zarrilli; Vittorio Colantuoni; Raffaella Faraonio; Stefano Casola; Elena Rossi; Carmelo B. Bruni

Insulin-like growth factor (IGF) II is a mitogenic polypeptide (1) that plays an important role in fetal and post-natal development (2). Both in human and rodents, IGF-II is a single copy gene that gives origin to a family of RNA transcripts (3-7). These heterogeneous mRNAs are originated from at least three promoters, functioning in many tissues of the rat during the embryonic and neonatal period (3,4,8). On the contrary, in adult animals, their expression is confined to the choroid plexus and to the leptomeninges (9). The human gene also utilizes three different promoters, two of them functioning in fetal liver and in most fetal tissues (5). The third one is a tissue specific promoter, active in adult liver only (6).


Cell Growth & Differentiation | 1994

Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells.

Raffaele Zarrilli; Sandro Pignata; Marco Romano; Gravina A; Stefano Casola; Carmelo B. Bruni; Angela Maria Acquaviva


Journal of Biological Chemistry | 1996

Constitutive Insulin-like Growth Factor-II Expression Interferes with the Enterocyte-like Differentiation of CaCo-2 Cells

Raffaele Zarrilli; Marco Romano; Sandro Pignata; Stefano Casola; Carmelo B. Bruni; Angela Maria Acquaviva


Oncogene | 1995

Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.

Stefano Casola; Paola Ungaro; Paolo V. Pedone; Lazzaro D; Fattori E; Ciliberto G; Raffaele Zarrilli; Carmelo B. Bruni; Andrea Riccio


Molecular Endocrinology | 1993

Extinction of insulin-like growth factor II gene expression in intratypic hybrids of rat liver cells.

Raffaele Zarrilli; Stefano Casola; A Conti; Carmelo B. Bruni; Vittorio Colantuoni


Molecular and Cellular Endocrinology | 1997

Relaxation of insulin-like growth factor-2 imprinting in rat cultured cells 1 This paper is dedicate

Paola Ungaro; Stefano Casola; Maria Vernucci; Paolo V. Pedone; Carmelo B. Bruni; Andrea Riccio

Collaboration


Dive into the Stefano Casola's collaboration.

Top Co-Authors

Avatar

Carmelo B. Bruni

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Andrea Riccio

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors

Avatar

Paolo V. Pedone

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Raffaele Zarrilli

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Paola Ungaro

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Marco Romano

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors

Avatar

Sandro Pignata

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Angela Maria Acquaviva

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Flavia Cerrato

Seconda Università degli Studi di Napoli

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge